Bayer to acquire Asklepios BioPharmaceutical in $4bn deal: A strategic move in gene therapy innovation

pharmanewsdaily- October 26, 2020 0

In a significant development within the pharmaceutical industry, German pharma giant Bayer has reached an agreement to acquire the US-based clinical-stage gene therapy company Asklepios ... Read More